MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Context Therapeutics (CNTX) Ownership - Who owns Context Therapeutics?

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
15
Web
https://www.contexttherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
34.24M
P/E Ratio
N/A
Total Cash
42.99M
Projected Growth
N/A
Total Debt
244.99K
Revenue
N/A
Risk (Beta)
-0.03
Dividend Yield
N/A
Total Cash/Share
0.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
CNTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for CNTX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
15
Web
https://www.contexttherapeutics.com
Who owns Context Therapeutics? CNTX symbol Ownership - Tickeron.com